Advanced in Hemolytic-Uremic Syndrome

Stephen D. Marks

Great Ormond Street Hospital For Children NHS Foundation Trust And NIHR GOSH Biomedical Research Centre, University College London Great Ormond Street Institute Of Child Health
London, ENG, GB 
Advanced in Hemolytic-Uremic Syndrome
Great Ormond Street Hospital For Children NHS Foundation Trust And NIHR GOSH Biomedical Research Centre, University College London Great Ormond Street Institute Of Child Health
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Stephen Marks practices in London, United Kingdom. Mr. Marks is rated as an Advanced expert by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Lupus Nephritis, Chronic Kidney Disease, Glomerulonephritis, Kidney Transplant, and Angioplasty.

His clinical research consists of co-authoring 221 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Hemolytic-Uremic Syndrome.

Gender
Male

Locations

Great Ormond Street Hospital for Children NHS Foundation Trust and NIHR GOSH Biomedical Research Centre, University College London Great Ormond Street Institute of Child Health
London, ENG, United Kingdom
Other Locations
Manchester, ENG M156GX, United Kingdom
Great Ormond Street Hospital for Children NHS Foundation Trust
Strete, ENG, United Kingdom
Bristol, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase 3 Open Label Randomised Multicentre Controlled Trial of Rituxmab and Mycophenolate Mofetil Without Oral Steroids for the Treatment of Lupus Nephritis
Phase 3 Open Label Randomised Multicentre Controlled Trial of Rituxmab and Mycophenolate Mofetil Without Oral Steroids for the Treatment of Lupus Nephritis
Enrollment Status: Terminated
Publish Date: February 01, 2018
Intervention Type: Drug
Study Phase: Phase 3

221 Total Publications

Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.
Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.
Journal: Nature reviews. Endocrinology
Published: August 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Marks's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 47 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile